記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND AND STUDY AIMS: Technical difficulty of endoscopic submucosal dissection (ESD) for colorectal neoplasms has not been resolved. The water pressure method (WPM) is a helpful technique for overcome difficulties with colorectal ESD. We evaluated the efficacy and safety of ESD with WPM (WPM-ESD) for colorectal neoplasms compared with conventional ESD (C-ESD). PATIENTS AND METHODS: This was a single-center, retrospective, observational study. Three hundred and eleven colorectal lesions were allocated into the WPM-ESD and the C-ESD groups, which were compared before and after propensity score matching. The main outcomes were procedure time, proportion of R0 resection, and incidence of adverse events (AEs) in the two groups. RESULTS: The WPM-ESD and C-ESD groups were allocated 134 and 177 lesions, respectively, and propensity score matching analysis created 92 matched pairs. Mean procedure time was significantly shorter in the WPM-ESD group (49 ± 26 vs. 58 ± 42 min, P = 0.032). All lesions were resected in one piece and there was no difference in the proportion of en bloc resection (100% vs. 100%) and R0 resection (92% vs. 96%, P = 0.536) or in incidence of intraoperative perforation (2.2% vs. 2.2%) in the two groups. CONCLUSIONS: WPM for colorectal ESD may shorten procedure time compared with C-ESD without increasing AEs.

DOI： 10.1055/a-2544-2654

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

OBJECTIVES: This systematic review and meta-analysis aimed to evaluate the diagnostic ability and examine the efficacy of countermeasures to adverse events of mucosal incision-assisted biopsy (MIAB) for gastric subepithelial tumors (SETs). METHODS: We performed a literature search and identified 533 relevant articles. Eleven articles, including 339 lesions, were ultimately used in the meta-analysis. The primary end-point was the pathological diagnostic rate of MIAB for gastric SETs, and the secondary end-point was the incidence of adverse events. The efficacy of acid secretion inhibitors in preventing postoperative bleeding and that of local injection before incision to prevent perforation were also examined. RESULTS: Nine studies were conducted in Japan and two in South Korea, of which only two were prospective studies. The pooled pathological diagnostic rate of MIAB for gastric SETs was 87.8% (95% confidence interval [CI] 80.2-94.0; I2 = 68.7%). The adverse event rate of the pooled population was 0.2% (95% CI 0-1.4; I2 = 0%). The acid secretion inhibitors significantly reduced postoperative bleeding (odds ratio 0.06, 95% CI 0.01-0.66, P = 0.02). Perforation occurred in 0% and 2.6% of the local and nonlocal injection cohorts, respectively, and the pathological diagnostic rates were 50% and 66.7%, respectively. CONCLUSIONS: MIAB is a reliable technique with a favorable diagnostic rate and few adverse events. Acid secretion inhibitors may effectively prevent postoperative bleeding; however, the efficacy of local injection remains unclear. This technique could be an option for tissue sampling in gastric SETs.

DOI： 10.1111/den.14933

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: Although a new potassium-competitive acid blocker (P-CAB) vonoprazan has been developed in Japan, no data are available regarding long-term vonoprazan or vonoprazan and acotiamide combination treatment in patients with functional dyspepsia (FD). METHODOLOGY: A total of 73 consecutive patients with FD diagnosed according to the Rome III classification were enrolled. Forty-two patients with FD were treated with vonoprazan monotherapy and thirty-one patients with FD were treated with vonoprazan and acotiamide combination therapy for 24 weeks. The levels of five pancreatic enzymes were measured, and the overall treatment efficacy (OTE) was defined as the ratio of FD patients with improved or unchanged in all items of GSRS and FD symptom scores after the treatment. RESULTS: Treatment with vonoprazan monotherapy and vonoprazan and acotiamide combination therapy significantly improved FD symptoms. There were no significant differences in OTE between patients treated with vonoprazan monotherapy (42.9%) and those treated with vonoprazan and acotiamide combination therapy (52%). There were no significant differences in duodenal eosinophilic infiltration between the improved and unimproved groups treated with vonoprazan alone and vonoprazan and acotiamide combination therapy, respectively. In contrast, there was a significant difference (P = 0.004) in the ratio of pancreatic enzyme abnormalities between the improved and unimproved patients treated with vonoprazan monotherapy and those treated with vonoprazan and acotiamide combination therapy. CONCLUSIONS: Long-term vonoprazan alone or vonoprazan and acotiamide combination therapy significantly improved each FD symptom. The OTE in patients treated with vonoprazan alone or vonoprazan and acotiamide combination therapy was only 50%. Long-term vonoprazan and acotiamide combination therapy may differentiate patients with pancreatic enzyme abnormalities from those with FD.

DOI： 10.7759/cureus.70371

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

AIMS: During intraoperative bleeding in endoscopic submucosal dissection (ESD), switching to spray coagulation may be beneficial compared with the continuous use of swift coagulation and can reduce the need for hemostatic forceps. We retrospectively assessed the effectiveness of spray modes on intraoperative bleeding during gastric ESD. METHODS AND RESULTS: A total of 316 bleeding events (156 in the Swift group and 160 in the Spray group) were consecutively recorded. In the Swift group, hemostasis was performed using the swift mode with a retracted tip of the needle-type knife, followed by the hemostatic forceps. In the Spray group, bleeding was treated in a stepwise manner: the swift mode, the spray mode, and the hemostatic forceps. All bleeding events were assigned to one of two groups by an endoscopist who retrospectively reviewed the videos. We compared the use of hemostatic forceps, the total hemostatic time, and the cumulative hemostasis rate between the two groups.The use of hemostatic forceps was significantly lower in the Spray group than in the Swift group (32.7% vs. 13.8%, P < 0.001). There was no significant difference in the total hemostatic time (Swift group, 20 s.; Spray group, 16 s.; P = 0.42), whereas the cumulative hemostasis rate with the knife was significantly higher in the Spray group (P = 0.007). CONCLUSION: The results suggested that spray coagulation from the tip of the needle-type knife could reduce the use of hemostatic forceps. In gastric ESD, spray coagulation may facilitate the hemostasis of intraoperative bleeding.

DOI： 10.1002/jgh3.70002

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Endoscopic hand suturing (EHS) was first developed to firmly close a mucosal defect following endoscopic submucosal dissection and has the potential for expanded applications. This study aimed to investigate the feasibility and safety of EHS in various clinical settings. In this single-center pilot study, 15 patients who had diseases with potential indications for EHS were prospectively recruited. Technical success, clinical success after the procedure, and severe EHS-related adverse events (AEs) were evaluated. EHS was applied for defect closure after gastric subepithelial lesion removal under laparoscopic observation (n = 9), defect closure after rectal endoscopic full-thickness resection (EFTR) (n = 2), defect closure after thoracoscopy-assisted esophageal EFTR (n = 1), mucosal closure for gastric ulcer bleeding (n = 1), mucosal closure after peroral endoscopic myotomy (POEM) (n = 1), and postoperative anastomotic leak (n = 1). EHS was completed without severe AEs and the clinical courses were also favorable in 13 patients (87%). The median suturing time was 61 minutes. In patients with POEM and anastomotic leak, EHS was discontinued because of the narrow lumen. In conclusion, EHS appears feasible and safe in situations.

DOI： 10.1055/a-2284-9492

PubMed

researchmap

記述言語：英語  

[This corrects the article DOI: 10.1055/a-2284-9492.].

DOI： 10.1055/a-2302-6845

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

OBJECTIVE: Mucosal incision-assisted biopsy (MIAB) has been introduced as an alternative to endoscopic ultrasound-guided fine needle aspiration for tissue sampling of subepithelial lesions. However, there have been few reports on MIAB, and the evidence is lacking, particularly in small lesions. In this case series, we investigated the technical outcomes and postprocedural influences of MIAB for gastric subepithelial lesions 10 mm or greater in size. METHODS: We retrospectively reviewed cases with the intraluminal growth type of possible gastrointestinal stromal tumors, in which MIAB was performed at a single institution between October 2020 and August 2022. Technical success, adverse events, and clinical courses following the procedure were evaluated. RESULTS: In 48 MIAB cases with a median tumor diameter of 16 mm, the success rate of tissue sampling and the diagnostic rate were 96% and 92%, respectively. Two biopsies were considered sufficient for making the definitive diagnosis. Postoperative bleeding occurred in one case (2%). In 24 cases, surgery has performed a median of two months after MIAB, and no unfavorable findings caused by MIAB were seen intraoperatively. Finally, 23 cases were histologically diagnosed as gastrointestinal stromal tumors, and no patients who underwent MIAB experienced recurrence or metastasis during a median observation period of 13 months. CONCLUSIONS: The data indicated that MIAB appears feasible, safe, and useful for histological diagnosis of gastric intraluminal growth types of possible gastrointestinal stromal tumors, even those of a small size. Postprocedural clinical effects were considered negligible.

DOI： 10.1002/deo2.264

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: Tumor size impacts the technical difficulty and histological curability of colorectal endoscopic submucosal dissection (ESD); however, the preoperative evaluation of tumor size is often different from histological assessment. Analyzing influential factors on failure to obtain an accurate tumor size evaluation could help prepare optimal conditions for safer and more reliable ESD. AIM: To investigate the tumor size discrepancy between endoscopic and pathological evaluations and the influencing factors. METHODS: This was a retrospective study conducted at a single institution. A total of 377 lesions removed by colorectal ESD at our hospital between April 2018 and March 2022 were collected. We first assessed the difference in size with an absolute percentage of the scaling discrepancy. Subsequently, we compared the clinicopathological characteristics of the correct scaling group (> -33% and < 33%) with that of the incorrect scaling group (< -33% or > 33%), which was further subdivided into the underscaling group (-33% or less of the discrepancy) and overscaling group (33% or more of the discrepancy), respectively. As secondary outcome measures, parameters on size estimation were compared between the underscaling and correct scaling groups, as well as between the overscaling and correct scaling groups. Finally, multivariate analysis was performed in terms of the following relevant parameters on size estimation: Pathological size, location, and possible influential factors (P < 0.1) in the univariate analysis. RESULTS: The mean of absolute percentage in the scaling discordance was 21%, and 91 lesions were considered to be incorrectly estimated in size. The incorrect scaling was significantly remarkable in larger lesions (40 mm vs 28 mm; P < 0.001) and less experience (P < 0.001), and these two factors were influential on the underscaling (75 lesions; P < 0.001). Conversely, compared with the correct scaling group, 16 lesions in the overscaling group were significantly small (20 mm vs 28 mm; P < 0.001), and the small lesion size was influential on the overscaling (P = 0.002). CONCLUSION: Lesions indicated for colorectal ESD tended to be underestimated in large tumors, but overestimated in small ones. This discrepancy appears worth understanding for optimal procedural preparation.

DOI： 10.4253/wjge.v16.i3.136

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND AND AIMS: An increasing number of patients are undergoing gastric endoscopic submucosal dissection (ESD) with active prescriptions of direct oral anticoagulants (DOACs). Only a few reports have described the effects of DOAC intake on postoperative bleeding. We aimed to investigate the bleeding risk associated with DOACs after gastric ESD. METHODS: Clinical studies published up to April 2022 showing bleeding rates after gastric ESD in patients taking DOACs were identified using electronic searches. The primary outcome was the rate of bleeding after gastric ESD in patients receiving DOACs compared to those not receiving antithrombotic therapy. In this meta-analysis, odds ratios (ORs) were calculated and pooled using a random effects model. The secondary outcome was the difference in the bleeding rate between patients treated with DOACs and those treated with warfarin and antiplatelet drugs. RESULTS: Seven studies were included in this meta-analysis. The pooled analysis showed that DOACs had a higher bleeding rate than non-thrombotic therapy (17.0% vs. 3.4%; OR 5.72; 95% confidence interval [CI], 4.33-7.54; I2 = 0%). The bleeding risk associated with DOAC administration was similar to that associated with warfarin (17.0% vs. 20.0%; OR 0.83; 95% CI 0.59-1.18; I2 = 0%), whereas it was higher than that associated with antiplatelet administration (16.9% vs. 11.0%; OR 1.63; 95% CI 1.14-2.34; I2 = 8%). CONCLUSIONS: This meta-analysis reveals that the bleeding risk of DOACs is higher than that of non-antithrombotics and antiplatelets, whereas it is comparable to that of warfarin. Gastric ESD in patients on anticoagulants requires careful postoperative management.

DOI： 10.1007/s10620-024-08271-6

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: Subclinical stricture after esophageal endoscopic submucosal dissection (ESD) makes the detection and re-ESD of metachronous lesions difficult. This study aimed to investigate the effectiveness of prophylactic steroid use after esophageal ESD for mucosal defects with a circumference less than 75% for the prevention of symptomatic and asymptomatic stricture. METHODS: In 80 retrospectively enrolled patients, we collected paired endoscopic images of a mucosal defects immediately after resection and a scar thereafter. After calculating circumference by image analysis software, all patients were classified into three groups in reference to mucosal defect circumference (MDC; ≤ 50%, 50-75%, ≥ 75%). Frequency of steroid use and symptomatic stricture were compared, and in < 75% MDC patients, a degree of asymptomatic stricture with or without steroid was compared by calculating a scar contraction rate (SCR). RESULTS: In the ≤ 50% (43 patients), 50-75% (27 patients) and ≥ 75% (10 patients) MDC groups, steroids were used in 12%, 59% and 100%, respectively, and symptomatic stricture occurred in 0%, 7% and 40%, respectively. In < 75% MDC patients, SCR in the steroid cohort was significantly lower than that in the nonsteroid cohort (42% vs. 65%, p = 0.002). No steroid-related adverse events occurred. CONCLUSION: Steroid use even for mucosal defects with < 75% circumference appears effective for the reduction of the risk on both symptomatic and asymptomatic stricture after esophageal ESD.

DOI： 10.1007/s00464-023-09988-7

PubMed

researchmap

記述言語：英語  

A 78-year-old man was admitted to our hospital with a tarry stool. Esophagogastroduodenoscopy identified tiny oozing on the greater curvature at the antrum. Despite repeated endoscopic hemostasis by coagulation and clipping, rebleeding occurred. On the third rebleeding, we performed endoscopic hand suturing to completely close the ulcer surface. Biopsy showing massive infiltration of eosinophils at the ulcer edge indicated eosinophilic gastritis. After the endoscopic closure by endoscopic hand suturing, the patient had no symptoms of bleeding thereafter and was discharged 19 days after the procedure by taking oral prednisolone. The patient remained well and was continuously treated with a small dose of steroids in outpatient. This is the first case report of the successful application of endoscopic hand suturing to a refractory hemorrhagic ulcer. Further accumulation of clinical experiences is desired to confirm the usefulness of this technique for the prevention of refractory ulcer bleeding.

DOI： 10.1002/deo2.207

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

INTRODUCTION: Endoscopic suturing of a mucosal defect is expected to prevent postoperative bleeding after endoscopic submucosal dissection (ESD). Endoscopic suturing causes mucosal deformity, which may interfere with endoscopic surveillance thereafter. We retrospectively investigated long-term chronological changes in mucosal suturing by endoscopic suturing. METHODS: Forty-three patients who underwent endoscopic hand suturing (EHS) after gastric ESD at three institutions were enrolled. First, our hypothesis that the suturing sites healed via inflammation, disappearance of mucosal inversion, and flattening was validated. Subsequently, the duration required to reach each healing step was evaluated. RESULTS: A total of 137 follow-up endoscopies were assessed, in which all cases showed the hypothesized chronological course on the suturing sites. The 95th percentiles of the duration when showing the disappearance of the inflammatory change and the inverted change were 63 days and 15.5 months after the procedure, respectively. DISCUSSION/CONCLUSION: The data show that the mucosal deformity induced by EHS disappeared within 16 months. Endoscopic suturing is thus considered to have a negligible effect on endoscopic surveillance following the procedure.

DOI： 10.1159/000527350

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

DOI： 10.1055/a-1884-0065

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: Endocytoscopy (ECS) aids early gastric cancer (EGC) diagnosis by visualization of cells. However, it is difficult for non-experts to accurately diagnose EGC using ECS. In this study, we developed and evaluated a convolutional neural network (CNN)-based system for ECS-aided EGC diagnosis. METHODS: We constructed a CNN based on a residual neural network with a training dataset comprising 906 images from 61 EGC cases and 717 images from 65 noncancerous gastric mucosa (NGM) cases. To evaluate diagnostic ability, we used an independent test dataset comprising 313 images from 39 EGC cases and 235 images from 33 NGM cases. The test dataset was further evaluated by three endoscopists, and their findings were compared with CNN-based results. RESULTS: The trained CNN required 7.0 s to analyze the test dataset. The area under the curve of the total ECS images was 0.93. The CNN produced 18 false positives from 7 NGM lesions and 74 false negatives from 28 EGC lesions. In the per-image analysis, the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were 83.2%, 76.4%, 92.3%, 93.0%, and 74.6%, respectively, with the CNN and 76.8%, 73.4%, 81.3%, 83.9%, and 69.6%, respectively, for the endoscopist-derived values. The CNN-based findings had significantly higher specificity than the findings determined by all endoscopists. In the per-lesion analysis, the accuracy, sensitivity, specificity, PPV, and NPV of the CNN-based findings were 86.1%, 82.1%, 90.9%, 91.4%, and 81.1%, respectively, and those of the results calculated by the endoscopists were 82.4%, 79.5%, 85.9%, 86.9%, and 78.0%, respectively. CONCLUSIONS: Compared with three endoscopists, our CNN for ECS demonstrated higher specificity for EGC diagnosis. Using the CNN in ECS-based EGC diagnosis may improve the diagnostic performance of endoscopists.

DOI： 10.1186/s12876-022-02312-y

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: It is unclear whether prophylactic endoscopic closure after colorectal endoscopic submucosal dissection (ESD) reduces the risk of postoperative adverse events due to variability in lesion characteristics. Therefore, we conducted a retrospective study using propensity score matching to evaluate the efficacy of prophylactic clip closure in preventing postoperative adverse events after colorectal ESD. METHODS: This single-center retrospective cohort study included 219 colorectal neoplasms which were removed by ESD. The patients were allocated into the closure and non-closure groups, which were compared before and after propensity-score matching. Post-ESD adverse events including major and minor bleeding and delayed perforation were compared between the two groups. RESULTS: In this present study, 97 and 122 lesions were allocated to the closure and non-closure groups, respectively, and propensity score matching created 61 matched pairs. The rate of adverse events was significantly lower in the closure group than in the non-closure group (8% vs. 28%, P = 0.008). Delayed perforation occurred in two patients in the non-closure group, whereas no patient in the closure group developed delayed perforation. In contrast, there were no significant differences in other postoperative events including the rate of abdominal pain; fever, white blood cell count, and C-reactive protein; and appetite loss between the two groups. CONCLUSIONS: Propensity score matching analysis demonstrated that prophylactic closure was associated with a significantly reduced rate of adverse events after colorectal ESD. When technically feasible, mucosal defect closure after colorectal ESD may result in a favorable postoperative course.

DOI： 10.1186/s12876-022-02259-0

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND AND AIMS: Surgery is recommended in early gastric cancer (EGC) after noncurative endoscopic submucosal dissection (ESD), although observation can be an alternative. We aimed to develop a tailor-made treatment strategy for noncurative EGCs by comparing the lymph node metastasis risk (LNMR) and the surgical risk. METHODS: We retrospectively identified 485 patients with differentiated-type, noncurative EGCs removed by ESD and classified them into two groups: a surgery-preferable group and an observation-preferable group, according to the clinical courses. Subsequently, LNMR and surgery-related death risk were assessed using a published scoring system and a risk calculator for gastrectomy, respectively. Finally, we investigated the optimal cutoff value of the risk difference (LNMR minus surgery-related death risk) to efficiently allocate these cases into either of two groups, surgery-preferable or observation-preferable. RESULTS: In 485 patients (surgery in 322, observation in 163), 57 and 428 patients were classified into the surgery-preferable group and the observation-preferable group, respectively. The optimal cutoff value of the risk difference (LNMR minus surgery-related death risk) to allocate the cases to the two preferable groups was 7.85 with the highest area under the curve (0.689). When cases with >7.85 LNMR over the surgery-related death risk were allocated into the surgery-preferable group and vice versa, the discriminability was 73.2%, which was sufficiently higher than that in the clinical decision (44.5%). CONCLUSION: Personalized comparison of LNMR and surgery-related death risk is helpful to provide a favorable treatment option for each patient with EGCs after noncurative ESD.

DOI： 10.1159/000523972

PubMed

researchmap

記述言語：英語  

Esophageal submucosal hematoma is a rare disease mainly caused by mechanical stimulation to the esophageal wall. We reported a case of esophageal submucosal hematoma after transesophageal echocardiography (TEE) which was performed during cardiovascular surgery. The stimuli of TEE insertion under general anesthesia and the perioperative use of multiple antithrombotic agents were considered as a possible cause. This is the first report of esophageal submucosal hematoma related to TEE, and endoscopic ultrasonography should be carefully performed in patients, particularly at bleeding tendency and without consciousness.

DOI： 10.1159/000525036

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND AND AIMS: Noninvasive, imaging diagnosis of gastrointestinal mesenchymal tumors (GIMTs) is still difficult. This study aimed to develop a novel diagnostic method of GIMTs via endoscopic ultrasonography (EUS) using circularity. METHODS: In a derivation series, we retrospectively collected 50 GIMTs 2-5 cm in diameter of two institutions. After selecting one EUS still image showing the maximal area per lesion, two endoscopists who were blind to the histological diagnosis assessed circularity, a surrogate indicator of roundness (range, 0-1; 1 = a true circle), with an image-analyzing software. Median circularity of three types of GIMT was compared, and the cutoff value to differentiate a group from other groups was presented by drawing a receiver operating characteristic curve. Subsequently, we assessed the diagnostic ability of circularity in 91 GIMTs which were retrospectively collected from the other two institutions by using the optimal cutoff value presented in the derivation series. RESULTS: The circularity in leiomyomas indicated 0.70 and was significantly lower than that of gastrointestinal stromal tumors (0.89), schwannomas (0.90), and their combined group. When leiomyomas were diagnosed as the circularity of <0.8305, which was presented as the optimal cutoff value, the diagnostic accuracy, sensitivity, and specificity in the validation series were 73.6%, 80.0%, and 72.4%, respectively. CONCLUSION: The data demonstrated that leiomyomas significantly exhibited more distortion than other GIMTs. That implies that the difference in shape, which is objectively determined as circularity, is useful to noninvasively discriminate leiomyomas from other GIMTs.

DOI： 10.1159/000523881

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

Prevention of postoperative anastomotic leakage in rectal surgery is still required. This study investigated the feasibility of endoscopic hand suturing (EHS) on rectal anastomosis ex vivo. By using isolated porcine colon, we prepared ten anastomoses 6-10 cm from the virtual anus. Then, we sutured anastomoses intraluminally by EHS, which involved a continuous suturing method in 5 cases and a nodule suturing method with extra corporeal ligation in 5 cases. Completeness of suturing, number of stitches, procedure time and presence of stenosis were investigated. Furthermore, the degree of stenosis was compared between the two suturing methods. In all cases, EHS were successfully completed. The median number of stitches and procedure time was 8 and 5.8 min, respectively. Stenosis was created in all continuous suturing cases whereas none was seen in nodule suturing cases. The shortening rate was significantly greater in the continuous suturing method than in the nodule suturing method. Intraluminal reinforcement of rectal anastomosis by EHS using nodule suturing with extra corporeal ligation is feasible without stenosis, which may be helpful as a countermeasure against possible postoperative anastomotic leakage in rectal surgery.

DOI： 10.1038/s41598-021-01396-y

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

With advancements in the development of flexible endoscopes and endoscopic devices and the increased demand for minimally invasive treatments, the indications of therapeutic endoscopy have been expanded. Methods of endoscopic treatment used for tissue removal, hemostasis, and dilatation are as follows. Endoscopic submucosal dissection (ESD) is considered the gold standard curative method for removal of gastrointestinal node-negative neoplasms, regardless of their size or the presence of ulcer formation. Laparoscopic endoscopic cooperative surgery (LECS), which incorporates ESD, was introduced for removal of lesions in deeper layers. Another technique is endoscopic full-thickness resection, which is challenging without the assistance of laparoscopy. In terms of hemostasis, management of iatrogenic bleeding after endoscopic treatment is an important issue. Shielding methods and suturing techniques have been introduced for large mucosal defects after ESD, and their efficacy has been investigated clinically. Peroral endoscopic myotomy (POEM) is a new alternative surgical approach for minimally invasive treatment of esophageal achalasia. Furthermore, endoscopic fundoplication after POEM was devised to prevent post-POEM gastroesophageal reflux disease. Many endoscopic treatments, including ESD, LECS, and POEM, have been introduced in Japan. With the aging of the population, more attention will be directed toward therapeutic endoscopy for elderly patients, because it is less invasive. Development of endoscopic treatments with expanded indications is expected.

DOI： 10.1272/jnms.JNMS.2021_88-109

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: Gastrointestinal muscular sampling is useful in the histological assessment of functional gastrointestinal disorders. We devised a new sampling method to obtain a large volume of muscle tissues and then investigated the feasibility and safety of endoscopic muscular resection with a ligation device in an in vivo porcine model. METHODS: After establishing a submucosal tunnel, a rubber band was placed on the muscle tissue by sucking the exposed muscle layer. Thereafter, the established pseudopolyp was removed using an electrocautery snare, and the entry site of the submucosal tunnel was closed endoscopically. This procedure was performed at three sites in the esophagus and stomach of two pigs. The technical success, histology, and survival rate on postoperative day 7 were examined postoperatively. RESULTS: We successfully completed the mentioned procedure in 11 of the 12 sites (92%), without the occurrence of severe adverse events. The median diameters of obtained tissues from the esophagus and stomach, respectively, were 5 mm and 10 mm. Histologically, both the inner and outer muscle layers were included in all specimens. The postprocedural course was found uneventful in both pigs during the observatory period. CONCLUSIONS: Endoscopic muscular resection using a ligation device enabled us to obtain large and thick muscle tissue samples. This approach may facilitate more precise histological assessments of functional gastrointestinal disorders.

DOI： 10.1272/jnms.JNMS.2021_88-602

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: Immune checkpoint inhibitors (ICIs) can induce immune-related adverse events (irAEs) including thyroid dysfunction. There are only a few reports on Graves' disease induced by ICIs. We report a case of new-onset Graves' disease after the initiation of nivolumab therapy in a patient receiving gastric cancer treatment. CASE PRESENTATION: The patient was a 66-year-old Japanese man, who was administered nivolumab (240 mg every 3 weeks) as a third-line therapy for stage IVb gastric cancer. His thyroid function was normal before the initiation of nivolumab therapy. However, he developed thyrotoxicosis before the third administration of nivolumab. Elevated, bilateral, and diffuse uptake of radioactive tracer was observed in the 99mTc-pertechnetate scintigraphy. Furthermore, the thyroid-stimulating hormone receptor antibody (TRAb) and thyroid-stimulating antibody (TSAb) test results, which were negative before the first administration of nivolumab, were positive after starting the therapy. The patient was diagnosed with Graves' disease, and the treatment with methimazole and potassium iodide restored thyroid function. CONCLUSIONS: This is the first complete report of a case of new-onset Graves' disease after starting nivolumab therapy, confirmed by diffusely increased thyroid uptake in scintigraphy and the positive conversion of antibodies against thyroid-stimulating hormone receptor. It is important to perform thyroid scintigraphy and ultrasonography to accurately diagnose and treat ICI-induced thyrotoxicosis, because there are various cases in which Graves' disease is developed with negative and positive TRAb titres.

DOI： 10.1186/s12902-020-00613-5

PubMed

researchmap

記述言語：英語   掲載種別：研究論文（学術雑誌）  

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome. Within the spectrum of NAFLD, non-alcoholic steatohepatitis (NASH) in combination with hepatic inflammation and fibrosis can lead to liver cirrhosis and hepatocellular carcinoma. Dysbiosis was reported to contribute to NASH pathogenesis. This study aimed to determine the effects of fructo-oligosaccharides (FOS) on steatohepatitis and visceral adiposity in an obese mouse model of NASH. METHODS: Twelve newborn C57BL/6 J male mice were subcutaneously injected with monosodium glutamate (MSG) to induce obesity on a conventional diet. Six mice were also administered 5% FOS via drinking water from 10 weeks of age. At 18 weeks, histological characteristics of the liver and epididymal fat were compared between the groups. Hepatic mRNA expression of lipid metabolism enzymes and SCFA in feces and sera were measured. RESULTS: Hepatic steatosis, inflammatory cell infiltration, and hepatocyte ballooning in the liver and increased hepatic mRNA expression of fatty acid synthase and glycerol-3-phosphate acyltransferase were observed in the MSG-treated mice. FOS treatment improved the liver pathology and blunted the increases in the mRNA expression levels of lipid metabolism enzymes. In addition, FOS inhibited adipocyte enlargement and formation of crown-like structures and reduced the M1 macrophage frequency in the epididymal fat of the MSG mice (39.4% ± 3.0% vs. 22.8% ± 0.7%; P = 0.001). FOS increased not only the fecal concentrations of n-butyric acid (0.04 ± 0.01 vs. 0.38 ± 0.14 mg/g, P = 0.02), propionic acid (0.09 ± 0.03 vs. 0.42 ± 0.16 mg/g, P = 0.02), and acetic acid (0.65 ± 0.16 vs. 1.48 ± 0.29 mg/g, P = 0.03) but also the serum concentration of propionic acid (3.9 ± 0.5 vs. 8.2 ± 0.5 μmol/L, P = 0.001). CONCLUSIONS: FOS ameliorates steatohepatitis, visceral adiposity, and chronic inflammation by increasing SCFA production.

DOI： 10.1186/s12876-020-01194-2

PubMed

researchmap

記述言語：日本語  

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2021&ichushi_jid=J02312&link_issn=&doc_id=20211105230047&doc_link_id=%2Faq9syokd%2F2021%2F0033s1%2F048%2F0259-0262%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faq9syokd%2F2021%2F0033s1%2F048%2F0259-0262%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

記述言語：日本語  

researchmap

記述言語：日本語  

H.pylori感染率が低下するなか、自己免疫性胃炎を診断する機会が増加している。自己免疫性胃炎はさまざまな胃病変を合併するが、本邦多施設共同研究によると過形成性ポリープ21.1%、1型神経内分泌腫瘍(NET)11.4%、胃癌9.8%の発生頻度であった。1型NETは大多数が小病変であるが、転移例も少数報告されており、その予後は良好と考えられている。自己免疫性胃炎に伴う胃癌の特徴は、(1)自己免疫性胃炎が高度に進行した悪性貧血を合併することが多い、(2)肉眼型は0-IIa型または0-I型の隆起型が多い、(3)局在はM領域が約半数だがL領域にも一定程度みられる、(4)組織型は分化型腺癌が多数を占め胃型粘液形質が優勢、(5)大多数が早期胃癌で進行胃癌は稀、である。(著者抄録)

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2021&ichushi_jid=J02312&link_issn=&doc_id=20210802080007&doc_link_id=%2Faq9syokd%2F2021%2F003307%2F008%2F1124-1133%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faq9syokd%2F2021%2F003307%2F008%2F1124-1133%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

記述言語：日本語  

researchmap

記述言語：日本語  

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2021&ichushi_jid=J02312&link_issn=&doc_id=20210624130003&doc_link_id=%2Faq9syokd%2F2021%2F003306%2F004%2F0963-0971%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faq9syokd%2F2021%2F003306%2F004%2F0963-0971%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

記述言語：日本語  

researchmap

記述言語：日本語  

＜文献概要＞はじめに 早期胃癌に対する内視鏡的粘膜下層剥離術(endoscopic submucosal dissection;ESD)は,その低侵襲性により耐術能の低い高齢者に対しても適応しやすい手技として認識されている.しかし,主な偶発症として挙げられる後出血は抗血栓薬の服用が危険因子の一つとされ,抗血栓薬の服用頻度の高い高齢者においては特に留意すべきものである.一方で,抗血栓薬休薬による血栓塞栓症のリスクも看過できず,安易な休薬は極めて重篤な合併症の引き金になりかねない.したがって,抗血栓薬服用者に対する胃ESDにおいては,抗血栓薬を継続することで可能な限り血栓塞栓症のリスクを回避しつつ,後出血のリスクを極力低減することが理想となる.

researchmap

記述言語：日本語  

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2020&ichushi_jid=J02312&link_issn=&doc_id=20200928130010&doc_link_id=%2Faq9syokd%2F2020%2F003209%2F011%2F1303-1308%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faq9syokd%2F2020%2F003209%2F011%2F1303-1308%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

記述言語：日本語  

食道胃接合部ポリープを「食道胃接合部(食道胃接合部上下2cm)に存在するポリープ」と定義し、病理所見と酸逆流所見(びらん性食道炎、1cm以上のBarrett食道)の有無によって、(1)酸逆流合併円柱上皮型、(2)酸逆流非合併円柱上皮型、(3)酸逆流合併扁平上皮型、(4)酸逆流非合併扁平上皮型、に分類した。食道胃接合部ポリープの約7割が酸逆流所見を合併し、ポリープは酸分泌抑制薬で消失してBarrett食道に置換された。酸逆流合併型は「Barrett食道粘膜由来ポリープ」ともいえる。一方、酸逆流非合併型にはHelicobacter pylori関連過形成性ポリープや乳頭腫(ヒトパピローマウイルス関連)などがあり、酸分泌抑制薬によるポリープ消失は期待できない。Barrett食道腺癌には食道胃接合部ポリープ類似型があるが、食道胃接合部ポリープの癌化例を筆者らは経験していない。食道胃接合部ポリープ類似型癌は酸分泌抑制薬で縮小する症例があり、酸逆流による炎症の関与が推定される。(著者抄録)

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2020&ichushi_jid=J02312&link_issn=&doc_id=20200827160006&doc_link_id=%2Faq9syokd%2F2020%2F003208%2F007%2F1148-1156%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faq9syokd%2F2020%2F003208%2F007%2F1148-1156%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

記述言語：日本語  

EUSガイド下腹腔神経節ブロック(EUS-CGN)は、従来行われてきたEUSガイド下腹腔神経叢ブロック(EUS-CPN)よりも高い疼痛緩和効果が期待できる。腹腔神経節の描出はコツさえつかめば容易であり、すべての症例において描出可能である。また、エタノールの注入量はEUS-CPNよりも少量ですむため、偶発症の発生も抑制できる可能性がある。効果的で安全なEUS-CGNを行うための手技の工夫について紹介した。(著者抄録)

researchmap

記述言語：日本語  

内視鏡的逆行性膵胆管造影(ERCP)におけるスコープ挿入の基本手技および困難例における対処法について解説した。ERCPで用いる後方斜視鏡は直視下にスコープを進めることができないため、安全かつ速やかに乳頭まで到達するには様々な注意点とコツが必要である。なかでも、挿入に際して最も重要なことは、抵抗を感じたら無理にスコープを押し込まず、スコープをいったん少し引き戻して進行方向を確認してから、再度スコープを進めることである。(著者抄録)

researchmap

記述言語：日本語  

癌性疼痛の管理は、近年WHOの除痛ラダーが推奨されている。しかし、種々の理由によりモルヒネを中心とした鎮痛薬による疼痛管理が困難な場合がある。一方、内視鏡技術の進歩により超音波内視鏡下腹腔神経叢ブロック(EUS-guided celiac plexus neurolysis:EUS-CPN)が近年行われるようになり、膵癌をはじめとする上腹部悪性腫瘍に伴う癌性疼痛の緩和治療に用いられている。超音波内視鏡下では、穿刺経路に介在する血管や臓器を避けて対象部位に正確な穿刺が行えるため、従来の方法と比べてはるかに手技の安全性が高い。さらに最近では、EUSによって腹腔神経節を視認できることが確認され、EUS-guided celiac ganglia neurolysis(EUS-CGN)も行われるようになっており、より一層の疼痛緩和効果が期待されている。(著者抄録)

researchmap

記述言語：日本語  

総胆管結石はバスケットやバルーンカテーテルを用いた内視鏡的結石除去術によりほとんどの症例で治療完遂可能であるが、2cmを超えるような大結石に対しては内視鏡的機械的砕石術(endoscopic mechanical lithotripsy:EML)を適宜併用した処置を行う必要がある。EML砕石具のシースは乳頭への挿入が他のデバイスと比べて難しく、軸合わせを意識した丁寧な挿入を心がけないと思わぬ偶発症を招く可能性がある。最近では新しい経口胆道鏡や、電気水圧衝撃波結石破砕装置(EHL)が相次いで発売されてきており、大結石に対する治療選択肢の幅が増えてきている。(著者抄録)

researchmap

記述言語：日本語  

古典的な胆管カニュレーションの方法は、造影剤を充填したカニューラの先端で胆管口を探ったのち、造影剤の注入によって胆管挿管の成否を確認する方法である。しかし、欧米では以前から十二指腸乳頭において見上げのポジションをとりやすいパピロトームを好んで使用する施設が多くあり、また最近ではガイドワイヤーを先行させて胆管を探るwire-guided cannulationが標準的な手技として定着している。また、胆管カニュレーション困難例については、従来、プレカット法が一般的に行われてきたが、国内では膵管ガイドワイヤー法/ダブルガイドワイヤー法も広く行われており、最近ではEUSを用いて胆管穿刺を行い、そこからガイドワイヤーを乳頭に出し、このガイドワイヤーを利用して胆管カニュレーションを行うEUSランデブー法の有用性が国内外から報告されている。(著者抄録)

researchmap

記述言語：日本語  

researchmap

開催年月日： 2025年3月

記述言語：日本語  

researchmap

開催年月日： 2025年2月

記述言語：日本語  

researchmap

開催年月日： 2025年1月

記述言語：日本語  

researchmap

開催年月日： 2025年1月

記述言語：日本語  

researchmap

開催年月日： 2025年1月

記述言語：日本語  

researchmap

開催年月日： 2024年10月

記述言語：日本語  

researchmap

開催年月日： 2024年10月

記述言語：日本語  

researchmap

開催年月日： 2024年1月

記述言語：日本語  

researchmap

開催年月日： 2024年1月

記述言語：日本語  

researchmap

開催年月日： 2024年

researchmap

開催年月日： 2024年

researchmap

開催年月日： 2023年12月

記述言語：日本語  

researchmap

開催年月日： 2023年10月

記述言語：日本語  

researchmap

開催年月日： 2023年10月

記述言語：日本語  

researchmap

開催年月日： 2023年10月

記述言語：日本語  

researchmap

開催年月日： 2023年10月

記述言語：日本語  

researchmap

開催年月日： 2023年10月

記述言語：日本語  

researchmap

開催年月日： 2023年10月

記述言語：日本語  

researchmap

開催年月日： 2023年10月

記述言語：日本語  

researchmap

開催年月日： 2023年9月

記述言語：日本語  

researchmap

開催年月日： 2023年7月

記述言語：日本語  

researchmap

開催年月日： 2023年7月

記述言語：日本語  

researchmap

開催年月日： 2023年7月

記述言語：日本語  

researchmap

開催年月日： 2023年6月

記述言語：日本語  

researchmap

開催年月日： 2023年6月

記述言語：日本語  

researchmap

開催年月日： 2023年6月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年4月

記述言語：日本語  

researchmap

開催年月日： 2023年3月

記述言語：日本語  

researchmap

開催年月日： 2023年2月

記述言語：日本語  

researchmap

開催年月日： 2023年1月

記述言語：日本語  

researchmap

開催年月日： 2023年1月

記述言語：日本語  

researchmap

開催年月日： 2023年1月

記述言語：日本語  

researchmap

開催年月日： 2023年1月

記述言語：日本語  

researchmap

開催年月日： 2023年1月

記述言語：日本語  

researchmap

開催年月日： 2023年1月

記述言語：日本語  

researchmap

開催年月日： 2023年1月

記述言語：日本語  

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2023&ichushi_jid=J03750&link_issn=&doc_id=20230116240016&doc_link_id=10.7143%2Fjhep.50.97&url=https%3A%2F%2Fdoi.org%2F10.7143%2Fjhep.50.97&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

開催年月日： 2022年12月

記述言語：日本語  

researchmap

開催年月日： 2022年10月

記述言語：日本語  

researchmap

開催年月日： 2022年10月

記述言語：日本語  

researchmap

開催年月日： 2022年10月

記述言語：日本語  

researchmap

開催年月日： 2022年10月

記述言語：日本語  

researchmap

開催年月日： 2022年10月

記述言語：日本語  

researchmap

開催年月日： 2022年10月

記述言語：日本語  

researchmap

開催年月日： 2022年9月

記述言語：日本語  

researchmap

開催年月日： 2022年6月

記述言語：日本語  

researchmap

開催年月日： 2022年6月

記述言語：日本語  

researchmap

開催年月日： 2022年4月

記述言語：日本語  

researchmap

開催年月日： 2022年4月

記述言語：日本語  

researchmap

開催年月日： 2022年4月

記述言語：日本語  

researchmap

開催年月日： 2022年4月

記述言語：日本語  

researchmap

開催年月日： 2022年4月

記述言語：日本語  

researchmap

開催年月日： 2022年2月

記述言語：日本語  

researchmap

開催年月日： 2022年1月

記述言語：日本語  

researchmap

開催年月日： 2022年1月

記述言語：日本語  

researchmap

開催年月日： 2022年1月

記述言語：日本語  

researchmap

開催年月日： 2021年10月

記述言語：日本語  

researchmap

開催年月日： 2021年10月

記述言語：日本語  

researchmap

開催年月日： 2021年10月

記述言語：日本語  

researchmap

開催年月日： 2021年9月

記述言語：日本語  

researchmap

開催年月日： 2021年9月

記述言語：日本語  

researchmap

開催年月日： 2021年9月

記述言語：日本語  

researchmap

開催年月日： 2021年9月

記述言語：日本語  

researchmap

開催年月日： 2021年6月

記述言語：日本語  

researchmap

開催年月日： 2021年4月

記述言語：日本語  

researchmap

開催年月日： 2021年4月

記述言語：日本語  

researchmap

開催年月日： 2021年4月

記述言語：日本語  

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2021&ichushi_jid=J02312&link_issn=&doc_id=20210426120002&doc_link_id=%2Faq9syokd%2F2021%2F003304%2F002%2F0671-0678%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Faq9syokd%2F2021%2F003304%2F002%2F0671-0678%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

開催年月日： 2021年1月

記述言語：日本語  

researchmap

開催年月日： 2021年1月

記述言語：日本語  

researchmap

開催年月日： 2021年1月

記述言語：日本語  

researchmap

開催年月日： 2021年1月

記述言語：日本語  

researchmap

開催年月日： 2021年1月

記述言語：日本語  

researchmap

開催年月日： 2020年12月

記述言語：日本語  

researchmap

開催年月日： 2020年12月

記述言語：日本語  

症例は63歳男性で、肺扁平上皮癌に対しペムブロリズマブを計31コース施行し部分奏功を維持していたが、開始から23ヵ月後より下痢を認め、32コース目を中止し入院した。入院時検査所見で軽度炎症反応上昇を認め、下部消化管内視鏡検査および病理組織所見で潰瘍性大腸炎に類似する所見を認めたことから、ペムブロリズマブによる免疫関連副作用(irAE)大腸炎と診断した。プレドニゾロンにより症状は軽快したが、漸減中に誤嚥性肺炎を合併し抗菌薬加療を行った。第70病日に偽膜性腸炎とCMV腸炎を同時合併し、メトロニダゾールおよびガンシクロビルにより症状改善を認めた。第105病日にirAE大腸炎を再燃したが軽症であり、メサラジンによる維持治療で半年経過している。

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2020&ichushi_jid=J04450&link_issn=&doc_id=20201225120035&doc_link_id=%2Fdw9poden%2F2020%2F009701%2F048%2F0130-0132%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdw9poden%2F2020%2F009701%2F048%2F0130-0132%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

開催年月日： 2020年12月

記述言語：日本語  

researchmap

開催年月日： 2020年12月

記述言語：日本語  

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2020&ichushi_jid=J04450&link_issn=&doc_id=20201225120001&doc_link_id=%2Fdw9poden%2F2020%2F009701%2F014%2F0024-0027%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdw9poden%2F2020%2F009701%2F014%2F0024-0027%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

開催年月日： 2020年12月

記述言語：日本語  

researchmap

開催年月日： 2020年12月

記述言語：日本語  

researchmap

開催年月日： 2020年12月

記述言語：日本語  

researchmap

開催年月日： 2020年10月

記述言語：日本語  

researchmap

開催年月日： 2020年10月

記述言語：日本語  

researchmap

開催年月日： 2020年9月

記述言語：日本語  

researchmap

開催年月日： 2020年8月

記述言語：日本語  

researchmap

開催年月日： 2020年5月

記述言語：日本語  

researchmap

開催年月日： 2020年5月

記述言語：日本語  

researchmap

開催年月日： 2020年2月

記述言語：日本語  

researchmap

開催年月日： 2020年1月

記述言語：日本語  

researchmap

開催年月日： 2019年10月

記述言語：日本語  

researchmap

開催年月日： 2019年6月

記述言語：日本語  

researchmap

開催年月日： 2019年6月

記述言語：日本語  

researchmap

開催年月日： 2019年5月

記述言語：日本語  

researchmap

開催年月日： 2019年5月

記述言語：日本語  

researchmap

開催年月日： 2019年4月

記述言語：日本語  

researchmap

開催年月日： 2019年2月

記述言語：日本語  

researchmap

開催年月日： 2018年10月

記述言語：日本語  

researchmap

開催年月日： 2018年7月

記述言語：日本語  

researchmap

開催年月日： 2018年7月

記述言語：日本語  

researchmap

開催年月日： 2018年6月

記述言語：日本語  

researchmap

開催年月日： 2018年4月

記述言語：日本語  

researchmap

開催年月日： 2018年4月

記述言語：日本語  

researchmap

開催年月日： 2018年4月

記述言語：日本語  

researchmap

開催年月日： 2018年4月

記述言語：日本語  

researchmap

開催年月日： 2017年12月

記述言語：日本語  

researchmap

開催年月日： 2017年9月

記述言語：日本語  

researchmap

開催年月日： 2017年9月

記述言語：日本語  

researchmap

開催年月日： 2017年9月

記述言語：日本語  

researchmap

開催年月日： 2017年6月

記述言語：日本語  

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2017&ichushi_jid=J04450&link_issn=&doc_id=20170621140005&doc_link_id=%2Fdw9poden%2F2017%2F009001%2F017%2F0062-0066%26dl%3D0&url=https%3A%2F%2Fwww.medicalonline.jp%2Fjamas.php%3FGoodsID%3D%2Fdw9poden%2F2017%2F009001%2F017%2F0062-0066%26dl%3D0&type=MedicalOnline&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00004_2.gif

開催年月日： 2017年6月

記述言語：日本語  

researchmap

開催年月日： 2017年4月

記述言語：日本語  

researchmap

開催年月日： 2017年4月

記述言語：日本語  

researchmap

開催年月日： 2017年4月

記述言語：日本語  

researchmap

開催年月日： 2017年1月

記述言語：日本語  

researchmap

開催年月日： 2017年1月

記述言語：日本語  

researchmap

開催年月日： 2016年12月

記述言語：日本語  

researchmap

開催年月日： 2016年12月

記述言語：日本語  

ERCP時の鎮痙薬としてl-menthol製剤を投与した359例を対象に、他の鎮痙薬を用いない手技完遂率、腸蠕動の程度、全処置時間、術中・術後の偶発症について検討した。その結果、他の鎮痙剤を用いない手技完遂率は90.5%で、鎮痙剤の追加の有無にかかわらず、手技を完遂できなかった症例は4.5%であった。鎮痙剤の追加を必要とした症例は34例(9.5%)であった。スコープ挿入からの総検査時間は中央値23分(2～102分)であった。l-menthol単独での腸蠕動は、grade別に各々none/mild/moderate/severeが27.9%/51.0%/15.3%/5.8%であった。偶発症は5%に認め、ERCP後膵炎が2.5%(重症0.5%)と最多であった。その他として、胆管穿孔を0.5%、十二指腸穿孔を0.2%、出血を0.2%、その他を1.6%に認めた。偶発症による死亡例、外科手術例はなかった。以上、l-menthol製剤はERCP時の鎮痙薬として有用であると考えられた。

researchmap

その他リンク： https://search.jamas.or.jp/default/link?pub_year=2016&ichushi_jid=J04450&link_issn=&doc_id=20170112130009&doc_link_id=10.11641%2Fpde.89.1_70&url=https%3A%2F%2Fdoi.org%2F10.11641%2Fpde.89.1_70&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

開催年月日： 2016年7月

記述言語：日本語  

researchmap